| 1 |
Al-Holou WN, Wang H, Ravikumar V, Shankar S, Oneka M, Fehmi Z, Verhaak RG, Kim H, Pratt D, Camelo-Piragua S, Speers C, Wahl DR, Hollon T, Sagher O, Heth JA, Muraszko KM, Lawrence TS, de Carvalho AC, Mikkelsen T, Rao A, Rehemtulla A. Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma. Neoplasia 2023;36:100872. [PMID: 36621024 DOI: 10.1016/j.neo.2022.100872] [Reference Citation Analysis]
|
| 2 |
Huang B, Zhang J, Zong W, Chen S, Zong Z, Zeng X, Zhang H. Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies. Front Immunol 2023;14:994698. [PMID: 36923402 DOI: 10.3389/fimmu.2023.994698] [Reference Citation Analysis]
|
| 3 |
Peng Z, Wu Y, Wang J, Gu S, Wang Y, Xue B, Fu P, Xiang W. Development and Validation of a Glioma-Associated Mesenchymal Stem Cell-Related Gene Prognostic Index for Predicting Prognosis and Guiding Individualized Therapy in Glioma.. [DOI: 10.21203/rs.3.rs-1928850/v1] [Reference Citation Analysis]
|
| 4 |
Ramuta TŽ, Kreft ME. Mesenchymal Stem/Stromal Cells May Decrease Success of Cancer Treatment by Inducing Resistance to Chemotherapy in Cancer Cells. Cancers 2022;14:3761. [DOI: 10.3390/cancers14153761] [Reference Citation Analysis]
|
| 5 |
Kim S, Lim E, Yoo K, Zhao Y, Kang J, Lim E, Shin I, Kang S, Lim HW, Lee S. Glioblastoma‐educated mesenchymal stem‐like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.997] [Reference Citation Analysis]
|
| 6 |
Petrilli LL, Fuoco C, Palma A, Pasquini L, Pericoli G, Grabovska Y, Mackay A, Rossi S, Carcaboso AM, Carai A, Mastronuzzi A, Jones C, Cesareni G, Locatelli F, Vinci M. Inter and intra-tumor heterogeneity of paediatric type diffuse high-grade gliomas revealed by single-cell mass cytometry. Front Oncol 2022;12:1016343. [PMID: 36568177 DOI: 10.3389/fonc.2022.1016343] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Al-holou WN, Wang H, Ravikumar V, Oneka M, Verhaak RG, Kim H, Pratt D, Camelo-piragua S, Speers C, Wahl DR, Shankar S, Hollon T, Sagher O, Heth JA, Muraszko KM, Lawrence TS, de Carvalho AC, Mikkelsen T, Rao A, Rehemtulla A. Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma.. [DOI: 10.1101/2021.09.10.459454] [Reference Citation Analysis]
|
| 8 |
Xue BZ, Xiang W, Zhang Q, Wang HF, Zhou YJ, Tian H, Abdelmaksou A, Xue J, Sun MX, Yi DY, Xiong NX, Jiang XB, Zhao HY, Fu P. CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells. Stem Cell Res Ther 2021;12:394. [PMID: 34256854 DOI: 10.1186/s13287-021-02458-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 9 |
Nowak B, Rogujski P, Janowski M, Lukomska B, Andrzejewska A. Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all. Biochim Biophys Acta Rev Cancer 2021;1876:188582. [PMID: 34144129 DOI: 10.1016/j.bbcan.2021.188582] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 10 |
Wang Y, Zhang F, Xiong N, Xu H, Chai S, Wang H, Wang J, Zhao H, Jiang X, Fu P, Xiang W. Remodelling and Treatment of the Blood-Brain Barrier in Glioma. Cancer Manag Res 2021;13:4217-32. [PMID: 34079374 DOI: 10.2147/CMAR.S288720] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 11 |
Cai X, Yuan F, Zhu J, Yang J, Tang C, Cong Z, Ma C. Glioma-Associated Stromal Cells Stimulate Glioma Malignancy by Regulating the Tumor Immune Microenvironment. Front Oncol 2021;11:672928. [PMID: 33996602 DOI: 10.3389/fonc.2021.672928] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 12 |
Zhang Q, Xiang W, Xue BZ, Yi DY, Zhao HY, Fu P. Growth factors contribute to the mediation of angiogenic capacity of glioma-associated mesenchymal stem cells. Oncol Lett 2021;21:215. [PMID: 33552293 DOI: 10.3892/ol.2021.12476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Crende O, García-Gallastegui P, Luzuriaga J, Badiola I, de la Hoz C, Unda F, Ibarretxe G, Pineda JR. Is There Such a Thing as a Genuine Cancer Stem Cell Marker? Perspectives from the Gut, the Brain and the Dental Pulp. Biology (Basel) 2020;9:E426. [PMID: 33260962 DOI: 10.3390/biology9120426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 14 |
Zhang Q, Zhang J, Tian Y, Zhu G, Liu S, Liu F. Efficacy of a novel double-controlled oncolytic adenovirus driven by the Ki67 core promoter and armed with IL-15 against glioblastoma cells. Cell Biosci 2020;10:124. [PMID: 33133514 DOI: 10.1186/s13578-020-00485-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 15 |
Pietrobono D, Giacomelli C, Marchetti L, Martini C, Trincavelli ML. High Adenosine Extracellular Levels Induce Glioblastoma Aggressive Traits Modulating the Mesenchymal Stromal Cell Secretome. Int J Mol Sci 2020;21:E7706. [PMID: 33081024 DOI: 10.3390/ijms21207706] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 16 |
Caruso FP, Garofano L, D'Angelo F, Yu K, Tang F, Yuan J, Zhang J, Cerulo L, Pagnotta SM, Bedognetti D, Sims PA, Suvà M, Su XD, Lasorella A, Iavarone A, Ceccarelli M. A map of tumor-host interactions in glioma at single-cell resolution. Gigascience 2020;9:giaa109. [PMID: 33155039 DOI: 10.1093/gigascience/giaa109] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 17 |
Clavreul A, Menei P. Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells? Cancers (Basel) 2020;12:E2628. [PMID: 32942567 DOI: 10.3390/cancers12092628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Xue BZ, Xiang W, Zhang Q, Wang YH, Wang HF, Yi DY, Xiong NX, Jiang XB, Zhao HY, Fu P. Roles of long non-coding RNAs in the hallmarks of glioma. Oncol Lett 2020;20:83. [PMID: 32863916 DOI: 10.3892/ol.2020.11944] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 19 |
Zhang Q, Liu F. Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas. Cell Death Dis 2020;11:485. [PMID: 32587256 DOI: 10.1038/s41419-020-2696-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 20 |
Dai X, Wang Y, Dong X, Sheng M, Wang H, Shi J, Sheng Y, Liu L, Jiang Q, Chen Y, Wu B, Yang X, Cheng H, Kang C, Dong J. Downregulation of miRNA-146a-5p promotes malignant transformation of mesenchymal stromal/stem cells by glioma stem-like cells. Aging (Albany NY) 2020;12:9151-72. [PMID: 32452829 DOI: 10.18632/aging.103185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 21 |
Caruso FP, Garofano L, D’angelo F, Yu K, Tang F, Yuan J, Zhang J, Cerulo L, Bedognetti D, Sims PA, Suvà M, Su X, Lasorella A, Iavarone A, Ceccarelli M. A MAP of tumor-host interactions in glioma at single cell resolution.. [DOI: 10.1101/827758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
